Semi-Annual Statement Of Income

STELLA PHARMA CORPORATION - Filing #7320249

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income
Statement of income
Net sales
269,491,000 JPY
229,067,000 JPY
Gross profit (loss)
217,298,000 JPY
206,944,000 JPY
Ordinary profit (loss)
-760,208,000 JPY
-775,974,000 JPY
Selling, general and administrative expenses
977,598,000 JPY
1,013,719,000 JPY
Extraordinary losses
768,000 JPY
JPY
Selling, general and administrative expenses
Depreciation
13,613,000 JPY
14,587,000 JPY
Operating profit (loss)
-760,300,000 JPY
-806,775,000 JPY
Profit (loss) before income taxes
-760,976,000 JPY
-775,974,000 JPY
Income taxes - current
2,772,000 JPY
2,850,000 JPY
Non-operating income
4,624,000 JPY
40,620,000 JPY
Non-operating income
Interest income
11,000 JPY
1,000 JPY
Interest on securities
1,428,000 JPY
1,425,000 JPY
Income taxes
2,772,000 JPY
2,850,000 JPY
Non-operating expenses
4,533,000 JPY
9,818,000 JPY
Profit (loss)
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY
Non-operating expenses
Interest expenses
2,084,000 JPY
2,580,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.